[Pharmacologic properties of fluorinated phenylethanolamine].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000818:Animals; D000431:Ethanol / Q000031:analogs & derivatives*; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology*; D007583:Jejunum / Q000187:drug effects; D010528:Peristalsis / Q000187:drug effects; D010626:Phenylethyl Alcohol / Q000494:pharmacology*; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000588:Amines; D006845:Hydrocarbons, Fluorinated; D013565:Sympatholytics; D000431:Ethanol; D010626:Phenylethyl Alcohol
Pharmakologische Eigenschaften fluorierter Phenyläthanolamine